Cargando…

Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing

Current criteria for identifying cancer patients suitable for immunotherapy with immune checkpoint blockers (ICBs) are subjective and prone to misinterpretation, as they mainly rely on the visual assessment of CD274 (best known as PD-L1) expression levels by immunohistochemistry (IHC). To address th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paluch, Benjamin E, Glenn, Sean T, Conroy, Jeffrey M, Papanicolau-Sengos, Antonios, Bshara, Wiam, Omilian, Angela R, Brese, Elizabeth, Nesline, Mary, Burgher, Blake, Andreas, Jonathan, Odunsi, Kunle, Eng, Kevin, He, Ji, Qin, Maochun, Gardner, Mark, Galluzzi, Lorenzo, Morrison, Carl D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356875/ https://www.ncbi.nlm.nih.gov/pubmed/27911273 http://dx.doi.org/10.18632/oncotarget.13691

Ejemplares similares

Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing
por: Wei, Lei, et al.
Publicado: (2016)

PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab
por: George, Saby, et al.
Publicado: (2018)

Development and analytical validation of a next-generation sequencing based microsatellite instability (MSI) assay
por: Pabla, Sarabjot, et al.
Publicado: (2019)

Whole-genome sequencing of a malignant granular cell tumor with metabolic response to pazopanib
por: Wei, Lei, et al.
Publicado: (2015)

PRAME expression and promoter hypomethylation in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2016)

Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing
por: Dy, Grace K., et al.
Publicado: (2019)

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
por: Morrison, Carl, et al.
Publicado: (2018)

Oncologist uptake of comprehensive genomic profile guided targeted therapy
por: Nesline, Mary K., et al.
Publicado: (2019)

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients
por: Pabla, Sarabjot, et al.
Publicado: (2019)

Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients
por: Zhang, Tian, et al.
Publicado: (2020)

Immune profiling and immunotherapeutic targets in pancreatic cancer
por: Lenzo, Felicia L., et al.
Publicado: (2021)

High focal adhesion kinase expression in breast carcinoma is associated with lymphovascular invasion and triple-negative phenotype
por: Golubovskaya, Vita M, et al.
Publicado: (2014)

Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
por: Conroy, Jeffrey M., et al.
Publicado: (2019)

Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancer
por: Tsuji, Takemasa, et al.
Publicado: (2020)

Prognostic value of histone chaperone FACT subunits expression in breast cancer
por: Attwood, Kristopher, et al.
Publicado: (2017)

NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
por: Ademuyiwa, Foluso O., et al.
Publicado: (2012)

Correction: NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
por: Ademuyiwa, Foluso O., et al.
Publicado: (2012)

Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation
por: Wang, Jianmin, et al.
Publicado: (2016)

Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease
por: Strohl, Anna, et al.
Publicado: (2016)

SimFFPE and FilterFFPE: improving structural variant calling in FFPE samples
por: Wei, Lanying, et al.
Publicado: (2021)

Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity
por: Kato, Shumei, et al.
Publicado: (2020)

Predictors of Immunosuppressive Regulatory T Lymphocytes in Healthy Women
por: Hampras, Shalaka S., et al.
Publicado: (2012)

The first malignant primary hepatic glomus tumor: A case report
por: Aversa, John G., et al.
Publicado: (2020)

GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation Study
por: Thaker, Premal H., et al.
Publicado: (2021)

Structural variation discovery in the cancer genome using next generation sequencing: Computational solutions and perspectives
por: Liu, Biao, et al.
Publicado: (2015)

Analysis of mutations in primary and metastatic synovial sarcoma
por: Xing, Zhuo, et al.
Publicado: (2018)

Immuno-stimultory/regulatory gene expression patterns in advanced ovarian cancer
por: Eng, Kevin H., et al.
Publicado: (2015)

A four gene signature predictive of recurrent prostate cancer
por: Komisarof, Justin, et al.
Publicado: (2016)

Preliminary validation of nCounter PanCancer immune profiling of FFPE slides and pbmc in CITN-05, a CITN study of the immunological effects of an IDO1 inhibitor in patients with ovarian carcinoma
por: Dennis, Lucas, et al.
Publicado: (2015)

Robust detection of translocations in lymphoma FFPE samples using targeted locus capture-based sequencing
por: Allahyar, Amin, et al.
Publicado: (2021)

An Isolated Mesenteric Presentation of a Nodal Peripheral T Cell Lymphoma with T Follicular Helper Cell Phenotype
por: Keogh, Anna, et al.
Publicado: (2022)

SCNVSim: somatic copy number variation and structure variation simulator
por: Qin, Maochun, et al.
Publicado: (2015)

Identification of robust reference genes for studies of gene expression in FFPE melanoma samples and melanoma cell lines
por: Christensen, Julie N., et al.
Publicado: (2020)

Tumor-associated macrophage expression of interferon regulatory Factor-8 (IRF8) is a predictor of progression and patient survival in renal cell carcinoma
por: Muhitch, Jason B., et al.
Publicado: (2019)

Evaluation of satisfaction with work–life balance among U.S. Gynecologic Oncology fellows: A cross-sectional study
por: Szender, J. Brian, et al.
Publicado: (2016)

RNA Sequencing Data for FFPE Tumor Blocks Can Be Used for Robust Estimation of Tumor Mutation Burden in Individual Biosamples
por: Sorokin, Maxim, et al.
Publicado: (2021)

USP1 Regulates TAZ Protein Stability Through Ubiquitin Modifications in Breast Cancer
por: Mussell, Ashley, et al.
Publicado: (2020)

A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors
por: Conroy, Jeffrey M., et al.
Publicado: (2021)

Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response
por: Pabla, Sarabjot, et al.
Publicado: (2021)

Determinants of RNA Quality from FFPE Samples
por: von Ahlfen, Silke, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_lbia2hrtpi9acitl9k8s8ch8o8